Trials / Completed
CompletedNCT05106465
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
Konect-MF: A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and MRI Measures of Brain Tissue Damage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to explore association patterns between digital outcome assessments from Konectom and MRI measures of brain tissue damage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Konectom platform | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2024-04-03
- Completion
- 2024-04-03
- First posted
- 2021-11-03
- Last updated
- 2024-05-17
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05106465. Inclusion in this directory is not an endorsement.